These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3141349)

  • 1. Spiramycin: in-vitro activity on Branhamella catarrhalis.
    Riou JY; Guibourdenche M
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():53-6. PubMed ID: 3141349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro comparative activity of five macrolides against 190 Branhamella catarrhalis strains].
    Chardon H; Bellon O; Bourgeois F; Lagier E
    Pathol Biol (Paris); 1989 May; 37(5):382-5. PubMed ID: 2506512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
    Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J
    Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
    Suermondt G; Denamur E; Laurans G; Orfila J
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):647-50. PubMed ID: 3141885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
    Laurans G; Gaudio F; Ducroix JP; Orfila J
    Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial susceptibility of 80 Moraxella catarrhalis strains isolated in the children's hospital of Tunis].
    Khemiri H; Smaoui H; Kechrid A
    Pathol Biol (Paris); 2008 May; 56(3):158-61. PubMed ID: 18178028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991.
    Fung CP; Powell M; Seymour A; Yuan M; Williams JD
    J Antimicrob Chemother; 1992 Jul; 30(1):47-55. PubMed ID: 1429336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
    Powell M; McVey D; Kassim MH; Chen HY; Williams JD
    J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
    Christensen JJ; Keiding J; Bruun B
    APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effect of cefixime against 200 strains of Branhamella catarrhalis. Comparison with cefotaxime].
    Chardon H; Bellon O; Lagier E; Giraud E
    Presse Med; 1989 Oct; 18(32):1556-9. PubMed ID: 2530531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
    Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
    Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilocus sequence typing-based analysis of Moraxella catarrhalis population structure reveals clonal spreading of drug-resistant strains isolated from childhood pneumonia.
    Du Y; Zhou H; Wang F; Liang S; Cheng L; Du X; Pang F; Tian J; Zhao J; Kan B; Xu J; Li J; Zhang F
    Infect Genet Evol; 2017 Dec; 56():117-124. PubMed ID: 29155241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I; Robbins M; Viljoen L; Brown DF
    J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note on susceptibility of Branhamella catarrhalis to heavy metals.
    Riley TV; Taylor ML
    J Appl Bacteriol; 1989 Aug; 67(2):185-9. PubMed ID: 2509410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.